PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PDAC - PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common diabetes drug boost chemotherapy against pancreatic cancer?
Disease control ENROLLING_BY_INVITATIONThis phase 2 trial investigates whether adding sitagliptin, a diabetes medication, to standard chemotherapy (gemcitabine and nab-paclitaxel) can improve outcomes for people with advanced pancreatic cancer that has not been treated before. The study enrolls 30 adults with locally …
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for pancreatic cancer: targeted drug enters final testing phase
Disease control OngoingThis phase 3 trial tests a new drug called daraxonrasib (RMC-6236) against standard treatments for people with metastatic pancreatic cancer that has already been treated. About 500 adults with a specific RAS gene mutation will be randomly assigned to receive either the new drug o…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Can digestive enzymes help pancreatic cancer patients keep weight on?
Disease control OngoingThis study tests whether taking pancreatic enzymes (Pertzye) with meals can help people with metastatic pancreatic cancer maintain their body weight during chemotherapy. The trial includes 17 participants who are starting a standard chemo regimen called FOLFIRINOX. Researchers wi…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New MRI scan may predict pancreatic cancer treatment success
Diagnosis TerminatedThis study tests whether a new type of MRI called 6D-MRI can predict how well pancreatic cancer patients respond to chemotherapy. Researchers will scan 36 patients before and during treatment to see if the MRI can spot signs of tumor activity and help guide surgery decisions. The…
Matched conditions: PDAC - PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC